Relationship of markers of muscle metabolism with the features of diet in patients on hemodialysis
https://doi.org/10.21886/2712-8156-2020-1-2-59-64
Abstract
Purpose: the Assessing of the relationship of the daily diet of dialysis patients with chronic kidney disease with a change in the levels of myostatin and protein kinase-β in order to determine the areas of potential impact on the development of protein-energy deficiency.
Materials and methods: тhe study included 80 patients with chronic kidney disease 5D. All patients underwent laboratory tests and the average daily diet was estimated from 3-day nutrition diaries. MSTN and AKT levels were determined in the blood by ELISA.
Results: in the study, the prevalence of PEW was 90%. We have proposed a catabolic muscle tissue index (CMTI), which takes into account the complex effect of the relationship between MSTN and AKT on the development of PEW. The daily calorie and protein in patients were less than recommended. The interconnections of dietary features and markers of catabolism of muscle tissue were determined, which is an area of potential interest in the prevention and progression of PEW and requires further study.
Conclusions: correction of the diet of dialysis patients is important for nutritional deficiency and control the catabolic way of the myostatin.
About the Authors
A. S. Kuzyarova
«DC Nephros-Don»
Russian Federation
Russian Federation
Angelina S. Kuzyarova, Cand. Sci. (Med.)
Rostov-on-Don
M. M. Batiushin
Rostov State Medical University
Russian Federation
Russian Federation
Mikhail M. Batiushin, Dr. Sci. (Med.), Prof.
Rostov-on-Don
A. A. Kastanayan
Rostov State Medical University
Russian Federation
Russian Federation
Alexander A. Kastanayan, Dr. Sci. (Med.), Prof.
Rostov-on-Don
E. S. Nasser El Dinе
«DC Nephros-Don»
Russian Federation
Russian Federation
Elena S. Nasser El Dinе
Rostov-on-Don
I. V. Fedorovich
«DC Nephros-Don»
Russian Federation
Russian Federation
Ivan V. Fedorovich
Rostov-on-Don
References
1. Ветчинникова О.Н., Пичугина И.С. Белково-энергетическая недостаточность у пациентов с хронической болезнью почек на диализной терапии. Москва: МОНИКИ 1775; 2015.
2. Obi Y., Qader H., Kovesdy C.Р., Kalantar-Zadeh K. Latest consensus and update on protein energy-wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18(3):254–262. https://doi.org/10.1097/MCO.0000000000000171.
3. Яковенко А.А., Лаврищева Ю.В., Румянцев А.Ш. Новые возможности скрининга белково-энергетической недостаточности у пациентов, получающих лечение программным гемодиализом. Нефрология и диализ. 2019;21(2):243-249. https://doi.org/10.28996/2618-9801-2019-2-243-249.
4. Кучер А.Г., Яковенко А.А., Лаврищева В.Ю., Асанина Ю.Ю. Особенности недостаточности питания и её коррекции у больных, получающих лечение программным гемодиализом. Нефрология. 2008;12(1):14-18. https://doi.org/10.24884/1561-6274-2008-12-1-14-18
5. Гасанов М.З., Батюшин М.М. mTOR и показатели саркопении у пациентов с хронической болезнью почек, получающих лечение гемодиализом. Нефрология. 2019;23(3):65- 69. https://doi.org/10.24884/1561-6274-2019-23-3-65-69
6. Fahal IH. Uraemic sarcopenia: aetiology and implications. Nephrology Dialysis Transplantation. 2014; 29(9):1655– 1665. https://doi.org/10.1093/ndt/gft070.
7. Wang X.H., Mitch W.E. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504– 516. https://doi.org/10.1038/nrneph.2014.112.
8. Delanaye P., Bataille S., Quinonez K., Buckinx F., Warling X., Krzesinski J., et al. Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. J Ren Nutr. 2019;29(6):511- 520. https://doi.org/10.1053/j.jrn.2018.11.010.
9. Schardong J., Marcolino M.Z., Plentz R.M. Muscle Atrophy in Chronic Kidney Disease. Advances in Experimental Medicine and Biology. 2018; In the book. Atrophy of muscles, p.393- 412. https://doi.org/10.1007/978-981-13-1435-3_18.
10. Кузярова А.С., Гасанов М.З., Батюшин М.М., Голубева О.В. Молекулярные основы мышечного истощения: роль миостатина и протеинкиназы-β в прогрессировании белково-энергетической недостаточности у пациентов на гемодиализе. Архивъ внутренней медицины. 2019; 9(2):126-132. https://doi.org/10.20514/2226-6704-2019-9-2-126-132.
11. Zha Y., Qian Q. Protein Nutrition and Malnutrition in CKD and ESRD. Nutrients. 2017;9(3):208. https://doi.org/10.3390/nu9030208.
12. Смирнов А.В., Голубев Р.В., Коростелева Н.Ю., Румянцев А.Ш. Снижение физической работоспособности у больных, получающих заместительную почечную терапию: фокус на саркопению. Нефрология. 2017;21(4):9-29. https://doi.org/10.24884/1561-6274-2017-21-4-9-29.
13. Румянцев А.Ш., Вишневский К.А. Скрининг белковоэнергетической недостаточности у пациентов диализных центров Санкт-Петербурга. Нефрология. 2015; 19(6): 34- 38. eLIBRARY ID: 24915669
14. Noori N., Kopple J., Kovesdy C., Feroze U., Sim J., Murali S., et al. Mid-Arm Muscle Circumference and Quality of Life and Survival in Maintenance Hemodialysis Patients. Clin J Am Soc Nephrol. 2010; 5(12): 2258–2268. https://doi.org/10.2215/CJN.02080310.
15. Wang X., Du J., Klein J., Mitch W. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009; 76(7):751-759. https://doi.org/10.1038/ki.2009.260.
Review
For citations:
Kuzyarova A.S., Batiushin M.M., Kastanayan A.A., Nasser El Dinе E.S., Fedorovich I.V. Relationship of markers of muscle metabolism with the features of diet in patients on hemodialysis. South Russian Journal of Therapeutic Practice. 2020;1(2):59-64. (In Russ.) https://doi.org/10.21886/2712-8156-2020-1-2-59-64
Views:
650
Email this article 